🇺🇸 FDA
Patent

US 8314128

Aminotetralin compounds as mu opioid receptor antagonists

granted A61KA61K47/12A61K47/14

Quick answer

US patent 8314128 (Aminotetralin compounds as mu opioid receptor antagonists) held by Theravance, Inc. expires Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Nov 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K47/12, A61K47/14, A61K47/26, A61K9/0019